Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CFG

Media Advisory - Minister Anand to highlight major milestone in Canada's COVID-19 response


MILTON, ON, July 26, 2021 /CNW/ - The Honourable Anita Anand, Minister of Public Services and Procurement, and the Honourable Patty Hajdu, Minister of Health, will highlight a major milestone in Canada's COVID-19 response. They will be joined by Guy Payette, President of Innomar Strategies, as well as representatives from vaccines suppliers and FedEx Express Canada.  

The event will be held indoors at a packaging warehouse, followed by a media availability.

Date:

Tuesday, July 27, 2021

Time:

11 am (ET)

Location:

8030 Esquesing Line, Unit B


Milton, Ontario

Notes for media:

Attention:

Follow us on Twitter

Follow us on Facebook

SOURCE Public Services and Procurement Canada


These press releases may also interest you

at 16:35
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME:...

at 16:35
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....

at 16:35
Hapbee Technologies, Inc. ("Hapbee" or the "Company"), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company ("Units") for aggregate gross proceeds to the...

at 16:30
Collaboration on TSMC's COUPE silicon photonics platform dramatically speeds chip-to-chip and machine-to-machine communication for cloud, datacenters, HPC, and AI chips / Key Highlights Ansys and TSMC deliver a high-fidelity multiphysics solution to...

at 16:30
The Board of Directors of The Cigna Group today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024....

at 16:30
Deverra Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic universal donor cell therapy treatments to fight cancer and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA)...



News published on and distributed by: